{
  "id": 638,
  "label": "platelet aggregation inhibitor",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "CHEBI:50427",
  "properties": {
    "definition": "A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 628,
      "label": "hematologic agent",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        178
      ],
      "type_id": 0,
      "properties": {
        "definition": "Drug that acts on blood and blood-forming organs and those that affect the hemostatic system."
      },
      "child_count": 2,
      "reference_id": "CHEBI:50248"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 628,
      "label": "hematologic agent"
    }
  ]
}